Wireless’ deep brain stimulation technique offers promising potential for neurodegenerative diseases BEIJING — Parkinson’s ...

With support from the U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Health (OASH), the National Institutes of Health (NIH) is leading the implementation of ...

With just over 100 days as CEO now under her belt, Catherine Owen Adams is looking to cruise rare disease-focused Acadia ...

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

Parkinson's disease (PD) is the second most common neurodegenerative disorder, primarily characterized by motor dysfunction.

Herbicide under US scrutiny over potential Parkinson's link First came the slow hand movements, then the tremor, and now the looming fear of what lies ahead. The US Environmental Protection Agency ...

Ketamine disrupts abnormal brain activity, offering long-term relief for Parkinson’s dyskinesia in early clinical trials.

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms of Parkinson's disease in Amsterdam this week, Amsterdam UMC reported. The ...

Neurological conditions are now the leading cause of ill health worldwide, yet remain an enigma. Meet the patients who baffle ...

For the people it affects (and anyone who shares a bed with them) restless legs syndrome (RLS) is a torturous condition.